Dermatologic: facial erythema, increased sweating, impaired wound healing, urticaria, edema.
Endocrine: decreased carbohydrate tolerance, development of cushingoid state, hirsutism, increased requirements for insulin in diabetic patients, menstrual irregularities, suppression of growth in children.
Fluid and Electrolyte Disturbances: congestive heart failure in susceptible patients, hypertension, hypokalemic alkalosis.
Gastrointestinal: abdominal distention, elevation in serum liver enzyme levels (usually reversible upon discontinuation), pancreatitis, peptic ulcer, ulcerative esophagitis.
Musculoskeletal: muscle weakness, osteoporosis, tendon rupture, vertebral compression fractures.
Neurological: convulsions, headache, increased intracranial pressure, psychic disorders, vertigo.
Ophthalmic: exophthalmos, glaucoma, increased intraocular pressure.
Other: increased appetite, malaise, nausea, weight gain.
View ADR Reporting Link